NEL Covid Medicines Delivery Unit for Non hospitalised patients
A Contract Award Notice
by NHS NORTH EAST LONDON INTEGRATED CARE BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £209K
- Sector
- HEALTH
- Published
- 21 Mar 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
London:
1 buyer
1 supplier
- WF Federated GP Network London
Description
NEL Covid Medicines Delivery Unit for Non-hospitalised patients
Total Quantity or Scope
NEL Covid Medicines Delivery Unit for Non hospitalised patients The current provider of the Service is meeting the contractual requirements to a satisfactory level and the intention is to award the providers the contract for the period 1st April 2025 to 30th September 2025 (with the option to extend to 31st March 2026), following PSR Direct Award Process C as there is no change to the contract terms. The approximate value of the contract for 12 months is £208,712.
Award Detail
| 1 | WF Federated GP Network (London)
|
Renewal Options
The contract can be extended for a further 6 months beyond the initial 6 month contract term.
Award Criteria
| The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard | 100 |
| price | 0 |
CPV Codes
- 85100000 - Health services
Indicators
- Options are available.
Legal Justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight 2 April 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight 2nd April 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award decision makers: Pharmacy senior management team were consulted regarding the options appraisal for the service. Investment review group 27th February 2025. There were no conflict of interest identified in the decision making process. The criteria for evaluation for Potential Future Performance had the following weighting : Quality and Innovation: 20%; Value for Money: 20%; Integration, Collaboration, and Service Sustainability: 20%; Improving Access, Reducing Health Inequalities, and Facilitating Choice: 30%; Social Value: 10% The criteria were applied with their respective weightings as specified. Current Performance: Assessed against Pass/Fail thresholds of overall score above.
Reference
- ocds-h6vhtk-04f715
- FTS 010565-2025